The Novelty of Ayahuasca Scale and the prediction of intentions to use
Brianna R. Altman, Maha N. Mian, Mitch Earleywine
Journal of Psychedelic Studies March 12, 2020 DOI: 10.1556/2054.2020.00117 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Cross-sectional survey Peer reviewed |
|---|---|
| Sample size | 139 |
| Population | Experienced hallucinogen users |
| Topics | Ayahuasca LSD Psilocybin |
| Keywords | Hallucinogen Novelty |
| Citations | 4 |
| Key findings | Expectancies for ayahuasca differ from those for other hallucinogens and influence intentions to use ayahuasca again, with positive connection expectancies increasing and physical reaction expectancies decreasing future use intentions. |
Abstract
Abstract Objective Given the growing popularity of ayahuasca and other hallucinogens, we sought to identify related expectancies and their role in why people might use this psychoactive brew rather than classic hallucinogens like LSD or psilocybin.
Method: Experienced users (N = 139) completed an online survey about their use of hallucinogens (including ayahuasca), how their ayahuasca experiences differed from those with other hallucinogens, as well as their intentions to use hallucinogens (including ayahuasca) in the future.
Results: Participants expected ayahuasca effects to differ meaningfully from the effects of other hallucinogens in multiple domains. Expected differences involved positive connections to nature (and other people), dramatic (or terrifying) thoughts, high variability of effects, and physical reactions. Intentions to use ayahuasca in the future increased as expectancies for positive connections increased, but decreased as physical reactions increased. One version of the full Novelty of Ayahuasca scale significantly covaried with the likelihood of using ayahuasca over other hallucinogens in the future, while another version did not. This result calls for further work examining how users perceive certain ayahuasca-induced effects.
Conclusions: These findings reveal that expectancies for ayahuasca differ from those for other hallucinogens, and impact an individual's willingness to try the substance again. Understanding these differences might help those who are interested in the therapeutic potential of hallucinogens decide among those available. Future studies might examine how these expectancies predict intentions to use ayahuasca (and other hallucinogens) longitudinally. Comparable approaches could also identify unique expectancies for other hallucinogens to see if those predict a preference for one over others.
Comparable studies
Other cross-sectional and survey studies on ayahuasca, most cited first.
| Study | Year | Design | Participants |
|---|---|---|---|
| Survey of subjective "God encounter experiences": Comparisons among naturally occurring experiences and those occasioned by the classic psychedelics psilocybin, LSD, ayahuasca, or DMT Adults reporting a single most memorable God encounter experience, either nondrug or... | 2019 | Cross-sectional survey | n = 4,285 |
| Adverse effects of ayahuasca: Results from the Global Ayahuasca Survey. Ayahuasca users from more than 50 countries who completed an online survey | 2022 | Cross-sectional survey | n = 10,836 |
| Ayahuasca in adolescence: a preliminary psychiatric assessment. Adolescents from a Brazilian ayahuasca sect and matched controls | 2005 | Controlled cross-sectional study | n = 80 |
| Psychological and neuropsychological assessment of regular hoasca users. Regular hoasca users from a U.S. branch of União do Vegetal and matched non-user controls | 2016 | Cross-sectional study | n = 57 |
| Indoleamine Hallucinogens in Cluster Headache: Results of the Clusterbusters Medication Use Survey People with cluster headache | 2015 | Cross-sectional survey | n = 496 |
Citations in the library
Cited by 4
- Effects of Ayahuasca on Gratitude and Relationships with Nature: A Prospective, Naturalistic Study. Journal of Psychoactive Drugs 2025
- Participation in an indigenous Amazonian-led ayahuasca retreat associated with increases in nature relatedness – a pilot study Drug Science, Policy and Law 2024
- Psychedelics for Psychiatric Disorders: Promise, Not Panacea Psychiatric Annals September 1, 2022
- Effects of ayahuasca on gratitude and relationships with nature: An open-label, naturalistic study June 7, 2023
Cites 37
- Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial Journal of Psychopharmacology November 30, 2016
- Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study. The Lancet Psychiatry May 17, 2016
- Rapid antidepressant effects of the psychedelic ayahuasca in treatment-resistant depression: a randomized placebo-controlled trial Psychological Medicine June 15, 2018
- Evidence for 5-HT2 involvement in the mechanism of action of hallucinogenic agents. Life Sciences December 17, 1984
- Survey study of challenging experiences after ingesting psilocybin mushrooms: Acute and enduring positive and negative consequences Journal of Psychopharmacology August 31, 2016
and 32 more in the library